AI drug discovery biotech AbCellera eyes record IPOAbCellera Biologics has been in the spotlight since coming up with Eli Lilly’s COVID-19 antibody drug bamlanivimab, and Share XAI drug discovery biotech AbCellera eyes record IPOhttps://pharmaphorum.com/news/ai-drug-discovery-biotech-abcellera-eyes-record-ipo/
Lilly’s antibody for COVID-19 protection starts nursing home trialWhile the world waits an effective coronavirus vaccine, Eli Lilly has started late-stage human testing an antibody drug Share XLilly’s antibody for COVID-19 protection starts nursing home trialhttps://pharmaphorum.com/news/lillys-antibody-for-covid-19-protection-starts-nursing-home-trial/
Lilly begins trial of COVID-19 antibody treatmentEli Lilly has started dosing patients in the world’s first trial for a medicine specifically designed to attack Share XLilly begins trial of COVID-19 antibody treatmenthttps://pharmaphorum.com/news/lilly-begins-trial-of-covid-19-antibody-treatment/
AbCellera and Eli Lilly join hunt for coronavirus therapyCanadian biotech AbCellera has joined forces with Eli Lilly to co-develop antibody products to prevent and treat COVID-19, Share XAbCellera and Eli Lilly join hunt for coronavirus therapyhttps://pharmaphorum.com/news/abcellera-and-eli-lilly-join-hunt-for-coronavirus-therapy/
